Results 81 to 90 of about 339,158 (270)
Subgraph densities in signed graphons and the local Sidorenko conjecture [PDF]
, 2010 We prove inequalities between the densities of various bipartite subgraphs in signed graphs and graphons. One of the main inequalities is that the density of any bipartite graph with girth r cannot exceed the density of the r-cycle.
Lovász, László
core +2 more sources
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Molecular Oncology, EarlyView.Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
On Signed Graphs Whose Two Path Signed Graphs Are Switching Equivalent To Their Jump Signed Graphs
, 2015 In this paper, we obtained a characterization of signed graphs whose jump signed graphs are switching equivalent to their two path signed graphs.
P. Siva Kota Reddy +2 more
openaire +1 more source
Molecular Oncology, EarlyView.CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak +10 more
wiley +1 more source
Molecular Oncology, EarlyView.Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Molecular Oncology, EarlyView.Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
On the existence of non-golden signed graphs
Atti della Accademia Peloritana dei Pericolanti : Classe di Scienze Fisiche, Matematiche e Naturali, 2018 A signed graph is a pair Γ=(G,σ), where G=(V(G), E(G)) is a graph and σ: E(G) → {+1, -1} is the sign function on the edges of G. For a signed graph we consider the least eigenvalue λ(Γ) of the Laplacian matrix defined as L(Γ)=D(G)-A(Γ), where D(G) is the
Maurizio Brunetti
doaj +1 more source
Molecular Oncology, EarlyView.Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Edges and vertices in a unique signed circle in a signed graph
AKCE International Journal of Graphs and Combinatorics, 2017 We examine the conditions under which a signed graph contains an edge or a vertex that is contained in a unique negative circle or a unique positive circle.
Richard Behr
doaj +1 more source
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
Molecular Oncology, EarlyView.IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source